Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Characteristics and Outcomes of Pediatric Patients with t(16;16)-AML: Results of a Case Series By the International BFM Study Group

Kim Klein, MD MSc, Valerie de Haas, MD PhD, Jonas Abrahamsson, MD PhD, Todd A Alonzo, PhD, Brenda Gibson, MD PhD, Christine J Harrison, PhD FRCPath, Henrik Hasle, MD PhD, Betsy A Hirsch, PhD, Guy Leverger, MD PhD, Franco Locatelli, MD PhD, Susana C. Raimondi, PhD, Jeffrey E Rubnitz, MD PhD, Dirk Reinhardt, MD PhD, Daisuke Tomizawa, MD PhD, Gertjan J.L. Kaspers, MD PhD

Blood (2017) 130 (Supplement 1): 2671.

https://doi.org/10.1182/blood.V130.Suppl_1.2671.2671

Published: 2017

Journal Articles

Identification of IRF8 As a Potent Tumor Suppressor in Murine Acute Promyelocytic Leukemia

Sangeetha Surianarayanan, Coline M Gaillard, Trevor Bentley, Matthew R. Warr, Briana Fitch, Huimin Geng, PhD, Emmanuelle Passegue, PhD, Hugues de Thé, MD PhD, Scott C. Kogan, MD

Blood (2016) 128 (22): 1518.

https://doi.org/10.1182/blood.V128.22.1518.1518

Published: 2016

Journal Articles

Rearrangements of Tyrosine Kinase (TK) Genes in Chronic Myeloproliferative Disorders (CMPD): A FISH Study

Paolo Bernasconi, MD, Irene Dambruoso, Marina Boni, Paola Maria Cavigliano, Ilaria Giardini, Barbara Rocca, Rita Zappatore, Marilena Caresana, Antonella Orlando, Ilaria Casetti, MD, Chiara Elena, MD, Elisa Rumi, MD, Mario Cazzola, MD

Blood (2016) 128 (22): 5493.

https://doi.org/10.1182/blood.V128.22.5493.5493

Published: 2016

Journal Articles

Unfavorable Prognostic Impact of MYC Increased Copy Number (ICN) in Patients with Diffuse Large B-Cell and High-Grade Lymphoma Treated with Immuno-Chemotherapy (ICT)

Francesca Schieppati, MD, Simona Fisogni, MD, Piera Balzarini, PhD, Alessandro Re, MD, Luisa Lorenzi, MD, Daniela Dalceggio, MD, Angela Passi, MD, Chiara Cattaneo, MD, Fabio Facchetti, MD, Giuseppe Rossi, MD, Alessandra Tucci, MD

Blood (2016) 128 (22): 5295.

https://doi.org/10.1182/blood.V128.22.5295.5295

Published: 2016

Journal Articles

Clinical Impact of Additional Cytogenetic Aberrations, cKIT- and RAS Mutations and Other Factors in Pediatric t(8;21)-AML

Blood (2014) 124 (21): 481.

https://doi.org/10.1182/blood.V124.21.481.481

Published: 2014

Journal Articles

Investigation of microRNAs Encoded By Chromosome 8 in Korean Patients with Myelodysplastic Syndrome

Seong-Ho Kang, MD PhD, Dae-Soo Moon, MD PhD, Myung-Hyun Nam, MD PhD, Soo-Young Yoon, MD PhD, Ji-Seon Choi, MD PhD

Blood (2014) 124 (21): 3257.

https://doi.org/10.1182/blood.V124.21.3257.3257

Published: 2014

Journal Articles

Therapeutic Strategies in Patients with Atypical CML (aCML) and Unclassified MDS/MPN (MDS/MPN-U). a Single Center Report

Thorsten Braun, Aziza Debache, Hervé Roudot, Daniel Lusina, Sylvain Thépot, Virginie Eclache, Antoine Martin, Juliette Soret, Stephanie Harel, Sabine Bréchignac, Charikleia Kelaidi, Lionel Adès, MD PhD, Pierre Fenaux, MD PhD, Claude Gardin

Blood (2014) 124 (21): 5610.

https://doi.org/10.1182/blood.V124.21.5610.5610

Published: 2014

Journal Articles

Therapeutic Strategy for Elderly Patients with ACUTE Myeloid Leukemia (AML) Carrying the DNMT3A Mutation

Elena Rossetti, MD, Monica Crugnola, MD, Cecilia Caramatti, MD, Luisa Craviotto, MD, Elena Masselli, MD, Lucia Prezioso, MD PhD, Alessandro Monti, MD, Benedetta Cambò, MD, Chiara Lambertini, MD, Claudio Pietropaolo, Anna Minardi, Gabriella Sammarelli, PhD, Sabrina Bonomini, Rodanthi Fioretzaki, MD, Franco Aversa, MD

Blood (2014) 124 (21): 5269.

https://doi.org/10.1182/blood.V124.21.5269.5269

Published: 2014

Journal Articles

Chromosome 8 Abnormalities (8p Losses and 8q Gains) in Patients with Chronic Lymphocytic Leukemia (CLL) and Del(17p)

Blood (2014) 124 (21): 5638.

https://doi.org/10.1182/blood.V124.21.5638.5638

Published: 2014

Journal Articles

Gene Amplifications In 84 Patients With Acute Myeloid Leukemia and 31 Patients With Myelodysplastic Syndrome Investigated By Array CGH

Andreas Roller, PhD, Simone Weber, Alexander Kohlmann, PhD, Melanie Zenger, Marita Staller, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 3724.

https://doi.org/10.1182/blood.V122.21.3724.3724

Published: 2013

Journal Articles

Identifying Informational Needs of Pathologists in the Diagnosis of Myelodysplastic Syndromes (MDS)

Chad Williamson, MS, MBA, B. Stephen Burton, MS, Terry Glauser, MD, MPH, Elizabeth M. Sagatys, MD, Christine Berger, BA, Patti Merwin, BSN, Mary Sugrue, MD

Blood (2012) 120 (21): 4242.

https://doi.org/10.1182/blood.V120.21.4242.4242

Published: 2012

Journal Articles

The Incidence of Central Nervous System Involvement in AML: A SAL-Tor Vergata Analysis

Nael Alakel, MD, Maria Ilaria Del Principe, Friedrich Stölzel, MD, Brigitte Mohr, Uta Oelschlaegel, PhD, Sergio Amadori, MD, Gerhard Ehninger, MD, Adriano Venditti, M.D., Markus Schaich, MD

Blood (2011) 118 (21): 4236.

https://doi.org/10.1182/blood.V118.21.4236.4236

Published: 2011

Journal Articles

Quantitative Whole Genome Analysis of Sequential Samples From Patients with B-CLL Identifies Novel Recurrent Copy Number Alterations Involving Critical B-Cell Transcription Factors

Adele Timbs, Sam Knight, Elham SadighiAkha, Adam Burns, Helene Dreau, Anne-Marie Hewitt, Chris Hatton, Chris Yau, Chris Holmes, Jenny Taylor, Anna Schuh

Blood (2010) 116 (21): 3590.

https://doi.org/10.1182/blood.V116.21.3590.3590

Published: 2010

Journal Articles

CBL, CBLB, TET2, ASXL1 , and IDH1/2 Mutations as Well as Additional Chromosomal Aberrations Constitute Molecular Events Contributing to Malignant Progression In Advanced Philadelphia Chromosome-Positive Disorders.

Hideki Makishima, MD, PhD, Anna Jankowska, MSC, Michael A McDevitt, MD, PhD, Simon Dujardin, Heather Cazzolli, Bartlomiej Przychodzen, Courtney Prince, John Nicoll, Siddaiah Harish, MD, Mohammed Shaik, MD, Eric Hsi, MD, Anjali Advani, MD, Ronald Paquette, MD, Jaroslaw P Maciejewski, MD, PhD, FACP

Blood (2010) 116 (21): 3396.

https://doi.org/10.1182/blood.V116.21.3396.3396

Published: 2010

Journal Articles

Myelodysplatic Syndrom

Jean-Richard Eveillard, MD, Jean-Christophe Ianotto, Adrian Tempescul, Gaelle Guillerm, Le Calloch Ronan, Anaïg Dagorne, Christian Berthou

Blood (2010) 116 (21): 4980.

https://doi.org/10.1182/blood.V116.21.4980.4980

Published: 2010

Journal Articles

Gain of the Centromeric Region of Chromosome 8, a New Germline Alteration In Juvenile Myelomonocytic Leukemia

Doris Steinemann, Tim Ripperger, Marcel Tauscher, Inka Praulich, Gudrun Göhring, Brigitte Pabst, Andrea Teigler-Schlegel, Brigitte Schlegelberger, Charlotte M Niemeyer, Christian Flotho

Blood (2010) 116 (21): 4830.

https://doi.org/10.1182/blood.V116.21.4830.4830

Published: 2010

Journal Articles

Outcome of Therapy-Related Acute Promyelocytic Leukemia (t-APL) with or without Arsenic Trioxide (ATO) as a Component of Frontline Therapy.

Farshid Dayyani, MD, PhD, Hagop M. Kantarjian, MD, Susan O'Brien, M.D., Sherry Pierce, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Jorge Cortes-Franco, MD, Farhad Ravandi, MD

Blood (2009) 114 (22): 1050.

https://doi.org/10.1182/blood.V114.22.1050.1050

Published: 2009

Journal Articles

C-Myc Mediated Regulation of Multidrug Resistance Genes in Chronic Myeloid Leukaemia Cd34+ Cell Progenitors.

Samuele Gherardi, Simona Soverini, Ph.D., Nunzio Iraci, Ph.D., Carolina Terragna, Ph.D., Emanuele Valli, Sandra Durante, Annalisa Astolfi, Ph.D., Roberto Bernardoni, Ph.D., Thea Kalebic, MD, Fabrizio Pane, MD, Giuseppe Saglio, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Giovanni Perini, Ph.D.

Blood (2009) 114 (22): 3252.

https://doi.org/10.1182/blood.V114.22.3252.3252

Published: 2009

Journal Articles

8p11–12 Myeloprolferative Syndrome: A Case Report and Brief Review of the Literature

Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD, PhD, Courtney Jackson, MD, Mark Lewis, MD, Mark M. Udden, MD

Blood (2008) 112 (11): 5260.

https://doi.org/10.1182/blood.V112.11.5260.5260

Published: 2008

Journal Articles

Recurrent Additional Genetic Aberrations and a Novel Mechanism of CBFB - MYH11 -Rearrangement in AML M4eo Are Detected Using High-Resolution Genome-Wide Single Nucleotide Polymorphisms (SNPs) Microarrays

Alexander Kohlmann, PhD, Sonja Rauhut, Frank Dicker, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2008) 112 (11): 3115.

https://doi.org/10.1182/blood.V112.11.3115.3115

Published: 2008

NARROW

Characteristics and Outcomes of Pediatric Patients with t(16;16)-AML: Results of a Case Series By the International BFM Study Group

Identification of IRF8 As a Potent Tumor Suppressor in Murine Acute Promyelocytic Leukemia

Rearrangements of Tyrosine Kinase (TK) Genes in Chronic Myeloproliferative Disorders (CMPD): A FISH Study

Unfavorable Prognostic Impact of MYC Increased Copy Number (ICN) in Patients with Diffuse Large B-Cell and High-Grade Lymphoma Treated with Immuno-Chemotherapy (ICT)

Clinical Impact of Additional Cytogenetic Aberrations, cKIT- and RAS Mutations and Other Factors in Pediatric t(8;21)-AML

Investigation of microRNAs Encoded By Chromosome 8 in Korean Patients with Myelodysplastic Syndrome

Therapeutic Strategies in Patients with Atypical CML (aCML) and Unclassified MDS/MPN (MDS/MPN-U). a Single Center Report

Therapeutic Strategy for Elderly Patients with ACUTE Myeloid Leukemia (AML) Carrying the DNMT3A Mutation

Chromosome 8 Abnormalities (8p Losses and 8q Gains) in Patients with Chronic Lymphocytic Leukemia (CLL) and Del(17p)

Gene Amplifications In 84 Patients With Acute Myeloid Leukemia and 31 Patients With Myelodysplastic Syndrome Investigated By Array CGH

Identifying Informational Needs of Pathologists in the Diagnosis of Myelodysplastic Syndromes (MDS)

The Incidence of Central Nervous System Involvement in AML: A SAL-Tor Vergata Analysis

Quantitative Whole Genome Analysis of Sequential Samples From Patients with B-CLL Identifies Novel Recurrent Copy Number Alterations Involving Critical B-Cell Transcription Factors

CBL, CBLB, TET2, ASXL1 , and IDH1/2 Mutations as Well as Additional Chromosomal Aberrations Constitute Molecular Events Contributing to Malignant Progression In Advanced Philadelphia Chromosome-Positive Disorders.

Myelodysplatic Syndrom

Gain of the Centromeric Region of Chromosome 8, a New Germline Alteration In Juvenile Myelomonocytic Leukemia

Outcome of Therapy-Related Acute Promyelocytic Leukemia (t-APL) with or without Arsenic Trioxide (ATO) as a Component of Frontline Therapy.

C-Myc Mediated Regulation of Multidrug Resistance Genes in Chronic Myeloid Leukaemia Cd34+ Cell Progenitors.

8p11–12 Myeloprolferative Syndrome: A Case Report and Brief Review of the Literature

Recurrent Additional Genetic Aberrations and a Novel Mechanism of CBFB - MYH11 -Rearrangement in AML M4eo Are Detected Using High-Resolution Genome-Wide Single Nucleotide Polymorphisms (SNPs) Microarrays

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only